AU Patent

AU2019259230B2 — Cannabidiol preparations and its uses

Assigned to Jazz Pharmaceuticals Research UK Ltd · Expires 2025-02-06 · 1y expired

What this patent protects

Cannabidiol (CBD) is a cannabinoid designated chemically as 2-[(1R,6R)-3-Methyl-6-(1- methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol. Its empirical formula is C

USPTO Abstract

Cannabidiol (CBD) is a cannabinoid designated chemically as 2-[(1R,6R)-3-Methyl-6-(1- methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol. Its empirical formula is C

Drugs covered by this patent

Patent Metadata

Patent number
AU2019259230B2
Jurisdiction
AU
Classification
—
Expires
2025-02-06
Drug substance claim
No
Drug product claim
No
Assignee
Jazz Pharmaceuticals Research UK Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.